Northwestern Mutual Wealth Management
CUE icon

Northwestern Mutual Wealth Management’s Cue Biopharma CUE Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.3K Hold
2,650
– – ﹤0.01% 2836
2025
Q4 		$24.3K Hold
2,650
– – ﹤0.01% 2668
2025
Q3 		$57.1K Sell
2,650
-117
-4% -$2.75K ﹤0.01% 2273
2025
Q2 		$56.6K Buy
2,767
+2,434
+731% +$51.9K ﹤0.01% 2204
2025
Q1 		$9.11K Buy
333
+250
+301% +$9.28K ﹤0.01% 2776
2024
Q4 		$2.73K Hold
83
– – ﹤0.01% 3106
2024
Q3 		$1.89K Buy
83
+66
+388% +$1.43K ﹤0.01% 3127
2024
Q2 		$620 Hold
17
– – ﹤0.01% 3264
2024
Q1 		$945 Sell
17
-12
-41% -$846 ﹤0.01% 3194
2023
Q4 		$2.28K Buy
29
+12
+71% +$858 ﹤0.01% 3035
2023
Q3 		$1.15K Hold
17
– – ﹤0.01% 3022
2023
Q2 		$1.82K Buy
+17
New +$2K ﹤0.01% 3001
2022
Q1 		– Sell
-2
Closed -$1K – 3162
2021
Q4 		$1K Buy
+2
New +$773 ﹤0.01% 3014

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Northwestern Mutual Wealth Management's CUE Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Cue Biopharma (CUE) position steady in Q1 2026 at 2,650 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

Northwestern Mutual Wealth Management first reported a position in CUE in Q4 2021 and has held it in 13 quarters since. The position peaked at $57.1K in Q3 2025. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Northwestern Mutual Wealth Management held 2,650 shares of Cue Biopharma worth $18.3K as of Q1 2026.
  • Northwestern Mutual Wealth Management left its Cue Biopharma share count unchanged in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2836 holding.
  • Northwestern Mutual Wealth Management first reported a position in Cue Biopharma in Q4 2021 and has held it in 13 quarters since.
  • Northwestern Mutual Wealth Management's Cue Biopharma position peaked at $57.1K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.